MedTrace Logo

SMS Reminders to Strengthen Demand for HPV Vaccination in Georgia

NCT05536674 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 55176

Last updated 2022-09-13

No results posted yet for this study

Summary

It is possible that achieving adequate HPV vaccination coverage will allow cervical cancer to be virtually eliminated. This is a priority for Georgia, where the burden of mortality and morbidity from cervical cancer is high and the yearly prevalence of cervical cancer is 14.5 per 100,000 population.

The objective of the intervention evaluated is to increase the uptake of the 1st dose of the HPV vaccination in Georgia. The intervention aims to achieve this by providing a SMS reminder informed by behavioural insights (BI) to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination, share information about the vaccine, and encourage them to book an appointment to receive the vaccination. Four different SMS messages will be compared to no SMS message.

The evaluation will be a 5-arm randomised controlled trial (RCT) which aims to answer the research question: Does each of the designed BI-informed SMS reminders increase the uptake of the first dose of the HPV vaccination among eligible girls in Georgia, compared to no reminder? Our hypothesis is that SMS reminders will increase the uptake of HPV vaccination.

Conditions

  • HPV, Human Papillomavirus Viruses, Human Papilloma Virus Vaccine

Interventions

BEHAVIORAL

SMS reminder for the HPV vaccination

A BI-informed SMS reminder to remind caregivers of girls between 10-12 years that their daughter is due the first dose of her HPV vaccination and share information about the vaccine.

Sponsors & Collaborators

  • UNICEF

    collaborator OTHER

  • National Center for Disease Control and Public Health, Georgia

    collaborator UNKNOWN

  • Information Technology Agency, Georgia

    collaborator UNKNOWN

  • The Behavioural Insights Team

    lead OTHER

Principal Investigators

  • Hannah Behrendt · Behavioural Insights Team

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
10 Years
Max Age
12 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-13
Primary Completion
2022-11-12
Completion
2022-11-12

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05536674 on ClinicalTrials.gov